In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
In the Lab
Christopher Klebanoff
New Immunotherapy Approach Targets a Commonly Mutated ‘Driver’ Protein Unique to Cancer Cells

Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer.
MSK patient Marc Scarduffa seen holding his dog at the beach.
Clinical Trials at MSK Aim To Reduce Side Effects of Cancer Treatment

Learn how MSK is Improving patients’ quality of life with less toxic treatments.
Feature
MSK director of social work Penny Damaskos, posing with a human-sized number 8
How Social Workers Help People with Cancer: 8 Questions with Penny Damaskos

Meet MSK Director of Social Work Penny Damaskos and learn how she and her team help people with cancer.
Linda Collins, an MSK patient, posing for a photo outside
Why Black Women Are Twice as Likely to Die of Endometrial Cancer — and What MSK Is Doing to Change It

Learn why Black women face a higher risk of death from endometrial cancer, and about a new effort led by Dr. Carol Brown at Memorial Sloan Kettering Cancer Center to close the gap.
Claire’s Legacy
MSK Giving: Claire’s Legacy

Learn why an MSK patient is supporting the MSK mission with a bequest.
Feature
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
MSK bile duct cancer patient Berta Pesantez
How MSK Is Making Cancer Clinical Trials in NYC Easier To Access

For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.
MSK thoracic surgeon and lung cancer specialist David Jones.
Inherited BRMS1 Mutation Promotes Lung Cancer Spread, MSK Research Suggests

An inherited mutation that contributes to lung cancer spread could be a target for therapies.
A researcher working in an MSK lab
MSK Research Highlights, March 28, 2024

New MSK research shows the effectiveness of cryoablation for large breast cancer tumors; helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.
Finding
Woman giving presentation at work
Study Highlights Workplace Difficulties Some Women Face During Cancer Treatment

Discover the role of the work environment in the life and career of an employee with cancer.